tradingkey.logo
tradingkey.logo
Buscar

Nuwellis Inc

NUWE
Añadir a la lista de seguimiento
3.150USD
+0.010+0.32%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
5.31MCap. mercado
2.31P/E TTM

Más Datos de Nuwellis Inc Compañía

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Información de Nuwellis Inc

Símbolo de cotizaciónNUWE
Nombre de la empresaNuwellis Inc
Fecha de salida a bolsaFeb 16, 2012
Director ejecutivoErb (John L)
Número de empleados38
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 16
Dirección12988 Valley View Rd
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344
Teléfono19523454200
Sitio Webhttps://www.nuwellis.com/
Símbolo de cotizaciónNUWE
Fecha de salida a bolsaFeb 16, 2012
Director ejecutivoErb (John L)

Ejecutivos de Nuwellis Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Nuwellis Inc?

Los cinco principales accionistas de Nuwellis Inc son: Mr. Gregory D. (Greg) Waller

¿Cuántas instituciones poseen acciones de Nuwellis Inc (NUWE)?

A fecha de 2026Q1, 20 instituciones poseen acciones de Nuwellis Inc, con un valor de mercado combinado de aproximadamente 135.71K, lo que representa el 6.78% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 58953.00.